Indirect comparison for Anti-TNF drugs in moderate to severe ulcerative colitis M. Galván-Banqueri, M.D. Vega-Coca, M.A. Castillo-Muñoz, C. Beltrán Calvo, T. Molina López

Serum levels of infliximab and adalimumab are associated with deep remission in inflammatory bowel disease Óscar Pascual-Marmaneu, María D. Belles-Medall, Raúl Ferrando-Piqueres, Pedro Almela-Notari, María Mendoza-Aguilera, Tamara Álvarez-Martín

Relationship between vedolizumab serum concentrations in the induction phase and early and sustained response in the first year of treatment in patients with ulcerative colitis José Germán Sánchez-Hernández, Noemí Rebollo, Fernando Muñoz, Nuria Padullés-Zamora, Marta Miarons, Nerea Martín Gutiérrez, Marcos Martín Gil, María José Otero